GS
DGX icon

GTS Securities’s Quest Diagnostics DGX Stock Holding History

GTS Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,600
Closed -$1.02M – 1969
2024
Q3 		$1.02M Buy
6,600
+3,100
+89% +$463K ﹤0.01% 2139
2024
Q2 		$479K Sell
3,500
-3,700
-51% -$507K ﹤0.01% 2737
2024
Q1 		$958K Sell
7,200
-1,100
-13% -$143K ﹤0.01% 2007
2023
Q4 		$1.14M Buy
8,300
+4,900
+144% +$644K ﹤0.01% 2063
2023
Q3 		$414K Buy
+3,400
New +$453K ﹤0.01% 2801

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

GTS Securities's DGX Position: Q1 2026 in Review

GTS Securities sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 1,270 shares — an estimated $220K sold.

GTS Securities first reported a position in DGX in Q4 2023 and held it in 6 quarters. The position peaked at $776K in Q1 2024. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • GTS Securities reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • GTS Securities sold 1,270 Quest Diagnostics shares in Q1 2026, an estimated $220K.
  • GTS Securities first reported a position in Quest Diagnostics in Q4 2023 and held it in 6 quarters.
  • GTS Securities's Quest Diagnostics position peaked at $776K in Q1 2024.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.